Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Turning the tables on drug discovery

26.05.2006


EUREKA project E! 2314 O’SCREEN reverses the traditional screening process used to discover potentially active new pharmaceutical compounds. Testing single, targeted molecules rather than tens of thousands it promises vastly increased efficiency in drug discovery.



Until now, new molecules with the potential to be developed as drugs have been discovered by screening thousands of candidate new molecules and developing those showing potential activity in some therapeutic area. But the process is extremely expensive and wasteful. Now, a radical new option couples this unique approach with bioinformatics resources.

Reverse approach


Project coordinator Dr Jean-Yves Berthon from French pharmaceuticals company Greentech explains the way this ‘reverse approach’ developed. “We have a large database of 30,000 plants, with information on their botany, physiology, chemical components and their applications; also another database on 300,000 natural molecules coming from plants. We reasoned that if we had an idea of what molecules would have a particular pharmaceutical effect, we could find a natural source in our databases.” Greentech’s partner in the project was Drug Discovery Ltd, part of the natural products business of the Strathclyde Institute for Drug Research in Scotland, which has focused on identifying lead molecules from natural sources for drug development.

The method starts with knowledge of the key enzymes involved in particular diseases, such as acetylcholinesterase in the case of Alzheimer’s disease. Project team biochemists researched and identified what chemical entities (ligands) could be attached to the enzyme to alter its behaviour. They then consulted the databases of plant-derived molecules and plants to discover the natural sources of the ligands which could influence the enzyme. Identified in this way substances can then be extracted from the identified plant material and subjected to early-stage potentiality testing.

Fast and effective

Once potential compounds are confirmed, they can be supplied to pharmaceutical companies under licence in an easy-to-use condition, coated onto microplates ready for further studies and the development of the drug substance. Developing new drugs in this way is much faster than using conventional screening. It is also possible to reduce the side effects of conventionally-developed drugs - as the potential drug has been designed to achieve a particular change on the enzyme involved in the illness, and is less likely to interact with other systems.

The success generated by this EUREKA project has enabled Greentech to found Greenpharma, a new company entirely dedicated to pharmaceutical discovery. The future looks even brighter as Greentech itself has tripled its turnover by applying the technique to cosmetics and nutraceuticals.

Catherine Shiels | alfa
Further information:
http://www.eureka.be/inaction/viewSuccessStory.do?docid=1719838

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>